I. Szokodi et al., INTRAPERICARDIAL INFUSION OF ENDOTHELIN-1 INDUCES VENTRICULAR ARRHYTHMIAS IN DOGS, Cardiovascular Research, 38(2), 1998, pp. 356-364
Objectives: Recently, extremely high levels of endothelin-l (ET-I) wer
e detected in the pericardial fluid of patients with heart disease; ho
wever, the pathophysiological importance of this finding is not known.
The present study was designed to characterize ET-I levels in canine
pericardial fluid and to investigate the effects of local high concent
rations of exogenous ET-I in vivo. Methods: In anesthetized, open-ches
t dogs ET-I (Groups 1 and 2,: 11 and 33 pmol kg(-1) min(-1); n = 6 and
6, respectively) or physiological saline (Group 3, n = 5) were infuse
d into the closed pericardial sac for 40 min. In serial pericardial fl
uid and aortic blood plasma samples, ET-I levels were measured by radi
oimmunoassay, and analysed by high-performance liquid chromatographp !
HPLC), Systemic arterial blood pressure, heart rate, cardiac output (C
O), standard ECG and right ventricular endocardial monophasic action p
otentials (MAPs) were recorded. Results: Basal pericardial fluid ET-I
levels were significantly higher than I respective plasma levels (342
+/- 210 vs. 8.0 +/- 5.2 pmol l(-1). n = 14, P < 0.001. In HPLC analysi
s pericardial fluid ET-I was indistinguishable from ET-1(1-21), Infusi
on of exogenous ET-I into the pericardial space induced ventricular ar
rhythmias in all instances, which were associated with 9.7-fold increa
se in pericardial fluid ET-I levels. Ventricular tachycardias develope
d in 9 of 12 animals, The arrhythmogenic affect of ET-I was more appar
ent in dogs with the larger dose. Before the onset of arrhythmias, int
rapericardial infusion of ET-I increased QT time (Group 1: 207 +/- 18
to 230 +/- 23 ms, P < 0.01; Group 2: 220 +/- 12 to 277 +/- 17 ms, P <
0.01) and MAP duration at 90% repolarization (at 300 ms cycle length)
(Group I: 192 +/- 9 to 216 +/- 9 ms, P < 0.01; Group 2: 205 +/- 9 to 2
55 +/- 9 ms, P < 0,001), Hemodynamic variables did not change signific
antly prior to the onset of ventricular tachyarrhythmias. In Group 3,
arrhythmias were not observed and all electrophysiological and hemodyn
amic parameters remained unchanged. Conclusions: Administration of exo
genous ET-I into the pericardial space induces ventricular arrhythmias
associated with prolongation of QT time and MAP duration. Whether per
icardial fluid ET-I under pathophysiological conditions can ever reach
sufficiently high levels to induce ventricular arrhythmias remains to
be elucidated. (C) 1998 Elsevier Science B.V. All rights reserved.